Complementary and alternative medicine in the treatment of chronic liver disease
暂无分享,去创建一个
[1] Jian-Gao Fan. Evaluating the efficacy and safety of Danning Pian in the short-term treatment of patients with non-alcoholic fatty liver disease: a multicenter clinical trial. , 2004, Hepatobiliary & pancreatic diseases international : HBPD INT.
[2] R. Hewawasam,et al. Hepatoprotective effect of Epaltes divaricata extract on carbon tetrachloride induced hepatotoxicity in mice. , 2004, The Indian journal of medical research.
[3] Shelly C. Lu,et al. S‐adenosylmethionine and its metabolite induce apoptosis in HepG2 cells: Role of protein phosphatase 1 and Bcl‐xS , 2004, Hepatology.
[4] C. Peine,et al. A randomized trial of Chinese herbal medicines for the treatment of symptomatic hepatitis C. , 2004, Archives of internal medicine.
[5] Jie-ping Yu,et al. Ginkgo biloba extract reverses CCl4-induced liver fibrosis in rats. , 2004, World journal of gastroenterology.
[6] I. Ramzan,et al. Kava Hepatotoxicity: Are we any closer to the truth? , 2004, Planta medica.
[7] E. Ernst,et al. Complementary and alternative therapies in the treatment of chronic hepatitis C: a systematic review. , 2004, Journal of hepatology.
[8] P. Muriel,et al. Effects of silymarin and vitamins E and C on liver damage induced by prolonged biliary obstruction in the rat. , 2004, Basic & clinical pharmacology & toxicology.
[9] L. El-Helw,et al. Phase II study of viscum fraxini-2 in patients with advanced hepatocellular carcinoma , 2004, British Journal of Cancer.
[10] N. Kaplowitz,et al. Clinical Perspectives on Xenobiotic‐Induced Hepatotoxicity , 2004, Drug metabolism reviews.
[11] Junli Zhang,et al. Effects of da ding feng zhu decoction in 30 cases of liver fibrosis. , 2003, Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan.
[12] P. Hayashi,et al. Vitamin E and vitamin C treatment improves fibrosis in patients with nonalcoholic steatohepatitis , 2003, American Journal of Gastroenterology.
[13] C. Lieber,et al. Silymarin Retards the Progression of Alcohol-Induced Hepatic Fibrosis in Baboons , 2003, Journal of clinical gastroenterology.
[14] Anton Rietveld,et al. Antioxidant effects of tea: evidence from human clinical trials. , 2003, The Journal of nutrition.
[15] E. Ernst,et al. Systematic review: hepatotoxic events associated with herbal medicinal products , 2003, Alimentary pharmacology & therapeutics.
[16] J. Sung,et al. Double‐blinded placebo‐controlled study of Phyllanthus urinaris for the treatment of chronic hepatitis B , 2003, Alimentary pharmacology & therapeutics.
[17] J. Neuberger,et al. Alternative medicines and the liver , 2003, Liver international : official journal of the International Association for the Study of the Liver.
[18] Fo-hu Jiang,et al. Effect of sea buckthorn on liver fibrosis: a clinical study. , 2003, World journal of gastroenterology.
[19] Mathias Schmidt,et al. Hepatotoxicity from Cimicifuga racemosa? Recent Australian case report not sufficiently substantiated. , 2003, Journal of alternative and complementary medicine.
[20] Nam-Cheol Kim,et al. Complete isolation and characterization of silybins and isosilybins from milk thistle (Silybum marianum). , 2003, Organic & biomolecular chemistry.
[21] T. Schiano. Hepatotoxicity and complementary and alternative medicines. , 2003, Clinics in liver disease.
[22] E. Ernst,et al. Antiviral agents from plants and herbs: a systematic review. , 2003, Antiviral therapy.
[23] V. Lawrence,et al. Milk thistle for the treatment of liver disease: a systematic review and meta-analysis. , 2002, The American journal of medicine.
[24] A. Clouston,et al. Black cohosh and other herbal remedies associated with acute hepatitis , 2002, The Medical journal of Australia.
[25] John M Colford,et al. Chinese herbal medicine and interferon in the treatment of chronic hepatitis B: a meta-analysis of randomized, controlled trials. , 2002, American journal of public health.
[26] Anne W. Taylor,et al. The escalating cost and prevalence of alternative medicine. , 2002, Preventive medicine.
[27] D. Schuppan,et al. Antifibrotic properties of botanicals in chronic liver disease. , 2002, Hepato-gastroenterology.
[28] Seung-Heon Hong,et al. INHIBITION OF TNF-α AND IL-6 PRODUCTION BY AUCUBIN THROUGH BLOCKADE OF NF-κB ACTIVATION IN RBL-2H3 MAST CELLS , 2002 .
[29] H. Kumada. Long-Term Treatment of Chronic Hepatitis C with Glycyrrhizin [Stronger Neo-Minophagen C (SNMC)] for Preventing Liver Cirrhosis and Hepatocellular Carcinoma , 2002, Oncology.
[30] M. Stewart,et al. Pyrrolizidine Poisoning: A Neglected Area in Human Toxicology , 2001, Therapeutic drug monitoring.
[31] T. Kaptchuk,et al. Perceptions about Complementary Therapies Relative to Conventional Therapies among Adults Who Use Both: Results from a National Survey , 2001, Annals of Internal Medicine.
[32] J. Hoofnagle,et al. Complementary and alternative medicine in chronic liver disease , 2001, Hepatology.
[33] Jianpin Liu,et al. Chinese medicinal herbs for chronic hepatitis B: a systematic review. , 2001, Liver.
[34] Bao-en Wang,et al. Treatment of chronic liver diseases with traditional Chinese medicine , 2000, Journal of gastroenterology and hepatology.
[35] Zhou Jiaju,et al. Traditional Chinese Medicines: Molecular Structures, Natural Sources, and Applications , 1999 .
[36] K. Okita,et al. Inhibitory effects of the herbal medicine Sho-saiko-to (TJ-9) on cell proliferation and procollagen gene expressions in cultured rat hepatic stellate cells. , 1998, Journal of hepatology.
[37] H. Rosen,et al. Milk Thistle (Silybum marianum) for the Therapy of Liver Disease , 1998, American Journal of Gastroenterology.
[38] M. Ott,et al. Phyllanthus amarus suppresses hepatitis B virus by interrupting interactions between HBV enhancer I and cellular transcription factors , 1997, European journal of clinical investigation.
[39] I. Chang. Antiviral activity of aucubin against hepatitis B virus replication , 1997 .
[40] T. Tango,et al. Prospective study of chemoprevention of hepatocellular carcinoma with sho‐saiko‐to (TJ‐9) , 1995, Cancer.
[41] B. Schneider,et al. Randomized controlled trial of silymarin treatment in patients with cirrhosis of the liver. , 1989, Journal of hepatology.
[42] Han‐Chieh Lin,et al. Protective mechanism of salvia miltiorrhiza on carbon tetrachloride-induced acute hepatotoxicity in rats. , 2003, Journal of pharmacological sciences.
[43] R. Batey,et al. Traditional Chinese medicine prevents inflammation in CCl4-related liver injury in mice. , 2003, The American journal of Chinese medicine.
[44] H. J. de Silva,et al. Liv.52 in alcoholic liver disease: a prospective, controlled trial. , 2003, Journal of ethnopharmacology.
[45] J P de la Cruz,et al. Effects of silymarin MZ-80 on oxidative stress in patients with alcoholic cirrhosis. Results of a randomized, double-blind, placebo-controlled clinical study. , 2002, International journal of clinical pharmacology and therapeutics.
[46] E. Williamson,et al. Synergy and other interactions in phytomedicines. , 2001, Phytomedicine : international journal of phytotherapy and phytopharmacology.
[47] R. D. de Man,et al. Review article: glycyrrhizin as a potential treatment for chronic hepatitis C. , 1998, Alimentary pharmacology & therapeutics.